Weaver DG[au] - Search Results

Year	Number of Results
2002	1
2004	1
2009	2
2014	1
2015	1
2016	1
2018	1
2020	2
2021	1
2023	0

1

Highly potent, broadly active antifungal agents for the treatment of invasive fungal infections.

Baugh SDP, Chaly A, Weaver DG, Pelletier JC, Thanna S, Freeman KB, Reitz AB, Scott RW. Baugh SDP, et al. Among authors: weaver dg. Bioorg Med Chem Lett. 2021 Feb 1;33:127727. doi: 10.1016/j.bmcl.2020.127727. Epub 2020 Dec 13. Bioorg Med Chem Lett. 2021. PMID: 33316410

2

Acinetobacter baumannii OxPhos inhibitors as selective anti-infective agents.

Rubin H, Selwood T, Yano T, Weaver DG, Loughran HM, Costanzo MJ, Scott RW, Wrobel JE, Freeman KB, Reitz AB. Rubin H, et al. Among authors: weaver dg. Bioorg Med Chem Lett. 2015 Jan 15;25(2):378-83. doi: 10.1016/j.bmcl.2014.11.020. Epub 2014 Nov 22. Bioorg Med Chem Lett. 2015. PMID: 25496770

3

A Novel Immunocompetent Mouse Model for Testing Antifungal Drugs Against Invasive Candida albicans Infection.

Ryan LK, Hise AG, Hossain CM, Ruddick W, Parveen R, Freeman KB, Weaver DG, Narra HP, Scott RW, Diamond G. Ryan LK, et al. Among authors: weaver dg. J Fungi (Basel). 2020 Sep 30;6(4):197. doi: 10.3390/jof6040197. J Fungi (Basel). 2020. PMID: 33007818 Free PMC article.

4

Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists.

Worm K, Weaver DG, Green RC, Saeui CT, Dulay DM, Barker WM, Cassel JA, Stabley GJ, DeHaven RN, LaBuda CJ, Koblish M, Brogdon BL, Smith SA, Dolle RE. Worm K, et al. Among authors: weaver dg. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5004-8. doi: 10.1016/j.bmcl.2009.07.057. Epub 2009 Jul 12. Bioorg Med Chem Lett. 2009. PMID: 19646869

5

Antifungal Potential of Host Defense Peptide Mimetics in a Mouse Model of Disseminated Candidiasis.

Chowdhury MH, Ryan LK, Cherabuddi K, Freeman KB, Weaver DG, Pelletier JC, Scott RW, Diamond G. Chowdhury MH, et al. Among authors: weaver dg. J Fungi (Basel). 2018 Feb 27;4(1):30. doi: 10.3390/jof4010030. J Fungi (Basel). 2018. PMID: 29495524 Free PMC article.

6

Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists.

Chu GH, Saeui CT, Worm K, Weaver DG, Goodman AJ, Broadrup RL, Cassel JA, DeHaven RN, LaBuda CJ, Koblish M, Brogdon B, Smith S, Le Bourdonnec B, Dolle RE. Chu GH, et al. Among authors: weaver dg. Bioorg Med Chem Lett. 2009 Oct 15;19(20):5931-5. doi: 10.1016/j.bmcl.2009.08.063. Epub 2009 Aug 21. Bioorg Med Chem Lett. 2009. PMID: 19736007

7

Investigation of Air-Liquid Interface Rings in Buffer Preparation Vessels: the Role of Slip Agents.

Shi T, Ding W, Kessler DW, De Mas N, Weaver DG, Pathirana C, Martin RD, Mackin NA, Casati M, Miller SA, Pla IA. Shi T, et al. Among authors: weaver dg. PDA J Pharm Sci Technol. 2016 May-Jun;70(3):272-81. doi: 10.5731/pdajpst.2015.005736. Epub 2016 Jan 21. PDA J Pharm Sci Technol. 2016. PMID: 26797969

8

Practical synthesis of aryl triflates under aqueous conditions.

Frantz DE, Weaver DG, Carey JP, Kress MH, Dolling UH. Frantz DE, et al. Among authors: weaver dg. Org Lett. 2002 Dec 26;4(26):4717-8. doi: 10.1021/ol027154z. Org Lett. 2002. PMID: 12489969

9

Stereoselective synthesis of a potent thrombin inhibitor by a novel P2-P3 lactone ring opening.

Nelson TD, LeBlond CR, Frantz DE, Matty L, Mitten JV, Weaver DG, Moore JC, Kim JM, Boyd R, Kim PY, Gbewonyo K, Brower M, Sturr M, McLaughlin K, McMasters DR, Kress MH, McNamara JM, Dolling UH. Nelson TD, et al. Among authors: weaver dg. J Org Chem. 2004 May 28;69(11):3620-7. doi: 10.1021/jo035794p. J Org Chem. 2004. PMID: 15152989

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year